Medical Research News and Research

RSS

Advocates warn about impact on medical research as debate about automatic cuts continues

Supporters of the National Institutes of Health argue that an anticipated $1.6 billion cut would undermine research in cancer, heart and AIDS, while adding to economic and unemployment woes.

10 Feb 2013

Nitric oxide shuts down brain's repair mechanisms

Nitric oxide, a gaseous molecule produced in the brain, can damage neurons. When the brain produces too much nitric oxide, it contributes to the severity and progression of stroke and neurodegenerative diseases such as Alzheimer's. Researchers at Sanford-Burnham Medical Research Institute recently discovered that nitric oxide not only damages neurons, it also shuts down the brain's repair mechanisms.

5 Feb 2013

USPTO issues patent to KAHR-101 for treatment of cancers, arthritis and MS

Hadasit Bio-Holdings Ltd., a publicly traded portfolio of biotech companies, based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that its portfolio company, KAHR Medical Ltd., was granted a U.S. patent approval (U.S. Patent No. 8329657).

5 Feb 2013

NFL funds WSU research to fix injured brains with new nerve cells

The National Football League thinks enough of the work that its charitable arm has given Krzysztof Czaja (pronounced K-shish-toff Chai-uh), a Washington State University neuroscientist, $100,000 to keep looking.

4 Feb 2013

U-M study takes in-depth look at public participation in medical research across the U.S.

Medical research is vital to the advancement of health care, but many medical research studies have too few people who participate. A new study from the University of Michigan takes an in-depth look at public participation in medical research across the United States.

3 Feb 2013

PKCζ protein plays a critical role in regulating tumor metabolism

Cancer cells need food to survive and grow. They're very good at getting it, too, even when nutrients are scarce. Many scientists have tried killing cancer cells by taking away their favorite food, a sugar called glucose. Unfortunately, this treatment approach not only fails to work, it backfires-glucose-starved tumors actually get more aggressive.

2 Feb 2013

Study shows how female steroid hormones can make changes to the breast genetic material

Melbourne scientists have discovered how female steroid hormones can make dramatic changes to the genetic material in breast cells, changes that could potentially lead to breast cancer.

2 Feb 2013

CBT and graded exercise therapy increase likelihood of recovery from chronic fatigue syndrome

Research led by Queen Mary, University of London, has shown that recovery from chronic fatigue syndrome (CFS) is possible for some patients, and has identified two treatments most likely to lead to recovery.

2 Feb 2013

SFU, Fraser Health poised to become medical technology leaders

Research endowment links SFU, Fraser Health as medical technology leaders Simon Fraser University and Fraser Health Authority are poised to become leaders in medical research and technology innovation with the launch of a $5.25 million Surrey Memorial Hospital Foundation B.C. Leadership Chair in Multimodal Technology for Healthcare Innovation.

2 Feb 2013

DHEA-S may prevent neurocognitive impairment that affects AIDS patients

A team of scientists from Canada, Thailand and Morocco have found that DHEA-S may prevent neurocognitive impairment that affects a significant percentage of AIDS patients. In a report appearing in the February 2013 issue of The FASEB Journal, they describe how a network of steroid molecules found in the brain, termed "neurosteroids," is disrupted during HIV infection leading to brain damage.

2 Feb 2013

Brandeis University researchers to receive Wiley Prize in Biomedical Sciences

Deborah E. Wiley, Chair of The Wiley Foundation, John Wiley & Sons, Inc., announced today that the twelfth annual Wiley Prize in Biomedical Sciences will be awarded to Dr. Michael Young, Rockefeller University, Dr. Jeffrey Hall, Brandeis University (Emeritus), and Dr. Michael Rosbash, Brandeis University.

1 Feb 2013

HIV infection rate in MSM in England and Wales remains unchanged despite improved prevention measures

The rate of new HIV infections among men who have sex with men (MSM) in England and Wales has remained unchanged over the past decade despite an almost four-fold increase in HIV testing, rising treatment coverage, and a 20% shortening of time-to-diagnosis, according to new research published Online First in The Lancet Infectious Diseases.

1 Feb 2013

Notch protein responsible for activating GATA2 gene to generate hematopoietic stem cells

Researchers from the group on stem cells and cancer at IMIM (Hospital del Mar Medical Research Institute) have deciphered one of the gene regulation circuits which would make it possible to generate hematopoietic blood cells, i.e. blood tissue stem cells.

1 Feb 2013

Three Robert Wood Johnson members win Edward J. Ill Excellence in Medicine Awards

Three members of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School faculty have been named 2013 recipients of the prestigious Edward J. Ill Excellence in Medicine Awards, highlighting their expertise as exceptional educators or researchers.

1 Feb 2013

Congenital sight impairment cure grows closer

A cure for congenital sight impairment caused by lens damage is closer following research by scientists at Monash University.

31 Jan 2013

Retired Jackson Laboratory scientist wins two major international science awards

Douglas Coleman, Ph.D., a retired Jackson Laboratory scientist whose work established the first clues to a genetic component in obesity, has won two major international science awards: the Frontiers of Knowledge Award in Biomedicine from the BBVA Foundation, based in Bilbao, Spain, and the King Faisal International Prize in Medicine from the Saudi Arabian King Faisal Foundation.

31 Jan 2013

Feinstein Institute, Merck Serono to develop antibodies for treatment of SLE

Merck Serono, a division of Merck, Darmstadt, Germany, and The Feinstein Institute for Medical Research, announced today that they will collaborate to develop antibodies for the treatment of systemic lupus erythematosus (SLE).

30 Jan 2013

Researchers unveil first maturation-based ‘disease in a dish’ model for ARVD/C

Most patients with an inherited heart condition known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) don't know they have a problem until they're in their early 20s. The lack of symptoms at younger ages makes it very difficult for researchers to study how ARVD/C evolves or to develop treatments. A new stem cell-based technology created by 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps solve this problem.

29 Jan 2013

Skin cells transformed into heart cells for research into cardiomyopathy

...

28 Jan 2013

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

The U. S. Patent and Trademark Office recently issued a patent to the U. S. Department of Health and Human Services involving resiniferatoxin, or RTX, an experimental compound that represents a potential new class of drugs to alleviate the intractable pain that can occur in people with advanced cancer, severe arthritis, and other extremely chronic conditions.

28 Jan 2013

Medical Research News and Research

Advocates warn about impact on medical research as debate about automatic cuts continues

Nitric oxide shuts down brain's repair mechanisms

USPTO issues patent to KAHR-101 for treatment of cancers, arthritis and MS

NFL funds WSU research to fix injured brains with new nerve cells

U-M study takes in-depth look at public participation in medical research across the U.S.

PKCζ protein plays a critical role in regulating tumor metabolism

Study shows how female steroid hormones can make changes to the breast genetic material

CBT and graded exercise therapy increase likelihood of recovery from chronic fatigue syndrome

SFU, Fraser Health poised to become medical technology leaders

DHEA-S may prevent neurocognitive impairment that affects AIDS patients

Brandeis University researchers to receive Wiley Prize in Biomedical Sciences

HIV infection rate in MSM in England and Wales remains unchanged despite improved prevention measures

Notch protein responsible for activating GATA2 gene to generate hematopoietic stem cells

Three Robert Wood Johnson members win Edward J. Ill Excellence in Medicine Awards

Congenital sight impairment cure grows closer

Retired Jackson Laboratory scientist wins two major international science awards

Feinstein Institute, Merck Serono to develop antibodies for treatment of SLE

Researchers unveil first maturation-based ‘disease in a dish’ model for ARVD/C

Skin cells transformed into heart cells for research into cardiomyopathy

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News